Skip to main content
SpringerLink
Log in

Considerations and Guidelines for Use of Anticoagulants and Antithrombotics in Patients Undergoing Interventional Pain Management

  • Chapter
  • First Online:
Essentials of Blood Product Management in Anesthesia Practice

  • 919 Accesses

Abstract

Anticoagulants and antithrombotics are commonly used medications that alter hemostasis. In patients undergoing interventional pain management, assessment for use of these drugs and monitoring of their effect is essential before performing any procedure to prevent adverse sequelae due to impaired hemostasis. Many herbals and over the counter medications can interfere with the coagulation cascade and have additive and/or synergistic effects. This chapter discusses commonly used anticoagulants and antithrombotics and recent guidelines to minimize the risks associated with each drug class in patients receiving interventional pain management.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Manchikanti L, Falco FJE, Benyamin RM, Caraway DL, Kaye AD, Helm S, et al. Assessment of bleeding risk of interventional techniques: a best evidence synthesis of practice patterns and perioperative management of anticoagulant and antithrombotic therapy. Pain Physician. 2013;16:SE261–318.

    PubMed  Google Scholar 

  2. Horlocker TT, Wedel DJ, Rowlingson JC, Enneking FK. Executive summary: regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy. Reg Anesth Pain Med. 2010;35(1):102–5.

    Article  Google Scholar 

  3. Manchikanti L, Abdi S, Atluri S, Benyamin RM, Boswell MV, Buenaventura RM, et al. An update of comprehensive evidence-based guidelines for interventional techniques in chronic spinal pain. Part II: guidance and recommendations. Pain Phys. United States. 2013;16:S49–283.

    Google Scholar 

  4. Meisenberg G, Simmons W. Hemostasis and Thrombosis. Principles of medical biochemistry. Saunders. 29th April 2011:p.608.

    Google Scholar 

  5. Smith SA, Travers RJ, Morrissey JH. How it all starts: Initiation of the clotting cascade. Crit Rev Biochem Mol Biol. 2015;50:326–36.

    Article  CAS  Google Scholar 

  6. Bahuleyan B. Hemostasis: a cell based model journal of physiology and pharmacology advances. J Phys Pharm Adv [Internet]. 2019;2015:638–42. Available from: www.grjournals.com.

    Google Scholar 

  7. Sadler JE, Budde U, Eikenboom JCJ, Favaloro EJ, Hill FGH, Holmberg L, et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost. John Wiley & Sons, Ltd (10.1111). 2006;4:2103–14.

    Article  CAS  Google Scholar 

  8. Mannucci PM, Tuddenham EGD. The Hemophilias — from royal genes to gene therapy. N Engl J Med. Massachusetts Medical Society. 2001;344:1773–9.

    Google Scholar 

  9. Sallah S, Bobzien W. Bleeding problems in patients with liver disease. Postgrad Med. Taylor & Francis. 1999;106:187–95.

    Article  CAS  Google Scholar 

  10. Weigert AL, Schafer AI. Uremic bleeding: pathogenesis and therapy. Am J Med Sci. 1998;316:94–104.

    CAS  PubMed  Google Scholar 

  11. Hawkey CJ. COX-1 and COX-2 inhibitors. Best Pract Res Clin Gastroenterol. 2001;15:801.

    Article  CAS  Google Scholar 

  12. Hamberg M, Svensson J, Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Nutr Rev. 2009;44:208.

    Article  Google Scholar 

  13. Bates SM, Greer A, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO. VTE, thrombophilia, antithrombotic therapy, and pregnancy – antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e691S–736S.

    Google Scholar 

  14. Patrono C, García Rodríguez LA, Landolfi R, Baigent C. Low-dose aspirin for the prevention of Atherothrombosis. N Engl J Med. 2005;353:2373.

    Article  CAS  Google Scholar 

  15. Vane JR, Botting RM. Anti-inflammatory drugs and their mechanism of action. Inflamm Res. 1998;47:78.

    Article  Google Scholar 

  16. Vermeer C, Vitamin K. The effect on health beyond coagulation – an overview. Food Nutr Res. 2012;56:5329.

    Google Scholar 

  17. Appadu B, Barber K. Drugs affecting coagulation. Anaesth Intensive Care Med. 2018;19:656.

    Google Scholar 

  18. DeLoughery TG. Warfarin. Hemostasis and Thrombosis. 3rd ed. Springer International Publishing. 2015:3. https://doi.org/10.1007/978-3-319-09312-3

  19. Hirsh J, Dalen JE, Anderson DR, Poller L, Bussey H, Ansell J, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 2001;119:8S.

    Article  CAS  Google Scholar 

  20. Cook NS, Kottirsch G, Zerwes HG. Platelet glycoprotein IIb/IIIa antagonists. Drugs Future. 1994.

    Google Scholar 

  21. Stangl PA, Lewis S. Review of currently available GP IIb/IIIa inhibitors and their role in peripheral vascular interventions. Semin Intervent Radiol. 2010;27:412.

    Article  Google Scholar 

  22. Ibanez B, Vilahur G, Badimon JJ. Pharmacology of thienopyridines: rationale for dual pathway inhibition. Eur Hear J Suppl. 2006;8:G3–9.

    Article  CAS  Google Scholar 

  23. Gray E, Mulloy B, Barrowcliffe TW. Heparin and low-molecular-weight heparin. Thromb Haemost. 2008;99(5):807–18. https://doi.org/10.1160/TH08-01-0032.

  24. Bussey H, Francis JL. Heparin overview and issues. Pharmacotherapy. 2004;24:103S.

    Article  CAS  Google Scholar 

  25. Di Nisio M, Middeldorp S, Büller HR. Direct thrombin inhibitors. N Engl J Med. 2005;353(10):1028–40.

    Article  Google Scholar 

  26. Lewis BE, Wallis DE, Berkowitz SD, Matthai WH, Fareed J, Walenga JM, et al. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation. 2001;103:1838.

    Article  CAS  Google Scholar 

  27. Larsen TB, Rasmussen LH, Skjøth F, Due KM, Callréus T, Rosenzweig M, et al. Efficacy and safety of dabigatran etexilate and warfarin in “real-world” patients with atrial fibrillation: A prospective nationwide cohort study. J Am Coll Cardiol. 2013;61:2264.

    Article  CAS  Google Scholar 

  28. Schulman S, Beyth RJ, Kearon C, Levine MN. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. American College of Chest Physicians. 2008;133:257S–98S.

    CAS  Google Scholar 

  29. Siegal DM, Curnutte JT, Connolly SJ, Lu G, Conley PB, Wiens BL, et al. Andexanet Alfa for the reversal of factor Xa inhibitor activity. N Engl J Med. 2015;373:2413–24.

    Article  CAS  Google Scholar 

  30. Shah R, Kaye AD, Kaye A, Tsai JY. Anticoagulation and regional anesthesia concerns. Essentials Reg Anesth. 2012;

    Google Scholar 

  31. Allen DJ, Chae-Kim SH, Trousdale DM. Risks and complications of Neuraxial Anesthesia and the use of anticoagulation in the surgical patient. Baylor Univ Med Cent Proc. 2002;15:369.

    Article  Google Scholar 

  32. Stafford-Smith M. Impaired haemostasis and regional anaesthesia. Can J Anaesth. 1996;43:R129–41.

    Article  CAS  Google Scholar 

  33. Ružman T, Gulam D, Drenjančević IH, Venžera-Azenić D, Ružman N, Burazin J. Factors associated with difficult neuraxial blockade. Local Reg Anesth. 2014;7:47–52.

    Article  Google Scholar 

  34. Claerhout AJ, Johnson M, Radtke JD, Zaglaniczny KL. AANA journal course: update for nurse anesthetists. Anticoagulation and spinal and epidural anesthesia. AANA J. 2004;72(3):225–31.

    PubMed  Google Scholar 

  35. Kaye AD, Manchikanti L, Novitch MB, Mungrue IN, Anwar M, Jones MR, et al. Responsible, safe, and effective use of antithrombotics and anticoagulants in patients undergoing interventional techniques: American Society of Interventional Pain Physicians (ASIPP) guidelines. Pain Physician. 2019;22:S1–74.

    Article  Google Scholar 

  36. Lumpkin MM. FDA public health advisory. Anesthesiology. 1998;88:27A–8A.

    Article  CAS  Google Scholar 

  37. Horlocker TT, Wedel DJ, Rowlingson JC, Enneking FK, Kopp SL, Benzon HT, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med. 2010;35:64–101.

    Article  CAS  Google Scholar 

  38. Harrop-Griffiths W, Cook T, Gill H, Hill D, Ingram M, Makris M, et al. Regional anaesthesia and patients with abnormalities of coagulation: the Association of Anaesthetists of Great Britain & Ireland the Obstetric Anaesthetists’ Association Regional Anaesthesia UK. Anaesthesia. 2013;68(9):966–72.

    Article  Google Scholar 

  39. Vela Vásquez RS, Peláez Romero R. Aspirin and spinal haematoma after neuraxial anaesthesia: Myth or reality? Br J Anaesth. 2015;115:688.

    Article  Google Scholar 

  40. Kaye AD, Manchikanti L, Novitch MB, Mungrue IN, Anwar M, Jones MR, et al. Responsible, safe, and effective use of antithrombotics and anticoagulants in patients undergoing interventional techniques: American Society of Interventional Pain Physicians (ASIPP) Guidelines. Pain Physician. 2019;22(1S):S75–S128.

    PubMed  Google Scholar 

  41. Moesker MJ, De Groot JF, Damen NL, Huisman MV, De Bruijne MC, Wagner C. How reliable is perioperative anticoagulant management ? Determining guideline compliance and practice variation by a retrospective patient record review. BMJ Open. 2019;9(7):e029879. https://doi.org/10.1136/bmjopen-2019-029879 PMID: 31320357 PMCID: PMC6661608.

  42. Arthroplasty A, Barlow BT, Hannon MT, Waldron JE. Preoperative management of abstract. 2019;00:1–9.

    Google Scholar 

  43. Horlocker TT, Wedel DJ, Rowlingson JC, Enneking FK, Kopp SL, Benzon HT, Brown DL, Heit JA, Mulroy MF, Rosen- quist RW, Tryba M, Yuan CS. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Fourth Edition). Reg Anesth Pain Med. 2018;43(3):263–309.

    Google Scholar 

  44. Horlocker TT, Bajwa ZH, Ashraf Z, Khan S, Wilson JL, Sami N, Peeters-Asdourian C, Powers CA, Schroeder DR, Decker PA, Warfield CA. Risk assessment of hemorrhagic complications associated with nonsteroidal antiinflammatory medications in ambulatory pain clinic patients undergoing epidural steroid injection. Anesth Analg. 2002;95(6):1691–7.

    Article  CAS  Google Scholar 

  45. Horlocker TT, Wedel DJ, Schroeder DR, Rose SH, Elliott BA, McGregor DG, Wong GY. Preoperative antiplatelet therapy does not increase the risk of spinal hematoma associated with regional anesthesia. Anesth Analg. 1995;80:303–9.

    CAS  PubMed  Google Scholar 

  46. Rechenmacher SJ, Fang JC. Bridging anticoagulation. J Am Coll Cardiol. Elsevier Inc. 2015;66:1392–403.

    Article  CAS  Google Scholar 

  47. Patel RB, Tassiopoulos AK. Anticoagulants and surgery: so many agents, so many taking them. Adv Surg. Elsevier Inc. 2019;53:235–51.

    Google Scholar 

  48. Shaw JR, Woodfine JD, Douketis J, Schulman S, Carrier M. Perioperative interruption of direct oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis. Res Pract Thromb Haemost. 2018;2(2):282–90.

    Article  CAS  Google Scholar 

  49. Haas E, Onel E, Miller H, Ragupathi M, White PF. A double-blind, randomized, active-controlled study for post-hemorrhoidectomy pain management with liposome bupivacaine, a novel local analgesic formulation. Am Surg. 2012;78(5):574–81.

    Article  Google Scholar 

  50. Coppens M, Eikelboom JW, Hart RG, Yusuf S, Lip GYH, Dorian P, et al. The CHA2DS2 -VASc score identifies those patients with atrial fibrillation and a CHADS 2 score of 1 who are unlikely to benefit from oral anticoagulant therapy. Eur Heart J. 2013;34:170–6.

    Google Scholar 

  51. Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, et al. Perioperative management of antithrombotic therapy. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e326S–50S.

    Article  CAS  Google Scholar 

  52. Spyropoulos AC, Douketis JD. How I treat anticoagulated patients undergoing an elective procedure or surgery. Blood. 2012;120(15):2954–62.

    Article  CAS  Google Scholar 

  53. Stangier J, Rathgen K, Sthle H, Mazur D. Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study. Clin Pharmacokinet. 2010;49(4):259–68.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, LSUHSC New Orleans, New Orleans, LA, USA

    Jordan S. Renschler, Amanda L. Granier, George M. Jeha, John E. Scheinuk, Matthew E. Nungesser, Joshua M. Etienne, Abigail P. Erwin & Erik M. Helander MD

  2. NYU Langone Health, NYU Langone Orthopedic Hospital, Department of Anesthesiology, Perioperative Medicine, and Pain Medicine, New York, NY, USA

    Chrissy Cherenfant

  3. NYU Langone Orthopedic, Department of Anesthesiology, Perioperative Care and Pain Medicine, New York, NY, USA

    Uchenna Umeh

  4. Middlemore Hospital, Department of Anaesthesia and Pain Medicine, Auckland, New Zealand

    Michael P. K. Webb

  5. Department of Anesthesiology and Pharmacology, Toxicology, and Neurosciences, Louisiana State University School of Medicine-Shreveport, Shreveport, LA, USA

    Alan David Kaye MD, PhD

  6. LSU Health Shreveport School of Medicine, New Orleans, LA, USA

    Alan David Kaye MD, PhD

  7. Tulane School of Medicine, New Orleans, LA, USA

    Alan David Kaye MD, PhD

Authors
  1. Jordan S. Renschler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amanda L. Granier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. George M. Jeha
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John E. Scheinuk
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Matthew E. Nungesser
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Joshua M. Etienne
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Abigail P. Erwin
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Chrissy Cherenfant
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Uchenna Umeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Michael P. K. Webb
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Erik M. Helander MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Alan David Kaye MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alan David Kaye MD, PhD .

Editor information

Editors and Affiliations

  1. NYU-Grossman School of Medicine, Department of Anesthesiology, New York, NY, USA

    Corey S. Scher

  2. Departments of Anesthesiology and Pharmacology Toxicology, and Neurosciences, Louisiana State University School of Medicine-Shreveport, Shreveport, LA, USA

    Alan David Kaye

  3. Department of Anesthesiology and Perioperative Medicine, Milton S. Hershey Medical Center, Penn State College of Medicine, Hershey, PA, USA

    Henry Liu

  4. NYU Grossman School of Medicine, Department of Anesthesiology, Perioperative Care and Pain Medicine, New York, NY, USA

    Seth Perelman

  5. NYU-Grossman School of Medicine, Department of Anesthesiology, New York, NY, USA

    Sarah Leavitt

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Renschler, J.S. et al. (2021). Considerations and Guidelines for Use of Anticoagulants and Antithrombotics in Patients Undergoing Interventional Pain Management. In: Scher, C.S., Kaye, A.D., Liu, H., Perelman, S., Leavitt, S. (eds) Essentials of Blood Product Management in Anesthesia Practice. Springer, Cham. https://doi.org/10.1007/978-3-030-59295-0_47

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-59295-0_47

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-59294-3

  • Online ISBN: 978-3-030-59295-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation